Latest Breaking News On - Better therapeutics inc - Page 1 : comparemela.com

MMCAP International Inc SPC Has $65,000 Stock Holdings in Better Therapeutics, Inc (NASDAQ:BTTX)

MMCAP International Inc. SPC trimmed its position in Better Therapeutics, Inc. (NASDAQ:BTTX – Free Report) by 77.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 356,270 shares of the company’s stock after selling 1,226,809 shares during the period. MMCAP International Inc. SPC’s […]

Better therapeutics incMmcap international incInternational incExchange commissionBetter therapeuticsFree reportVisit holdingschannelBetter therapeutics daily

Click Therapeutics Accelerates Expansion into Obesity and Cardiometabolic Disease With Acquisition of the Assets of Better Therapeutics, Inc

Click Therapeutics, Inc. ("Click"), a leader in Digital Therapeuticstm as prescription medical treatments, today announced plans to accelerate its development initiatives in obesity and cardiometabolic disease through the acquisition of the assets of.

Chan chiuBetter therapeutics incClick therapeutics incProduct serviceBoehringer ingelheimTherapeutics accelerates expansionCardiometabolic disease with acquisitionBetter therapeuticsDigital therapeuticstmDevice designationRich denunzioChief commercial officerBetter therapeuticChief technology officerRegulatory considerationsPrescription drug use related

Delisting of Securities of Better Therapeutics, Inc ; Tritium DCFC Limited; Arcimoto, Inc ; Next e GO N V ; Acutus Medical, Inc ; and NeuBase Therapeutics, Inc from The Nasdaq Stock Market

Delisting of Securities of Better Therapeutics, Inc ; Tritium DCFC Limited; Arcimoto, Inc ; Next e GO N V ; Acutus Medical, Inc ; and NeuBase Therapeutics, Inc from The Nasdaq Stock Market
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Neubase therapeutics incNasdaq incArcimoto incBetter therapeutics incAcutus medical incGlobenewswire incStock marketBetter therapeuticsAcutus medicalNeubase therapeuticsNasdaq webNasdaq rule

Global Digital Therapeutics (DTx) Market Report 2024-2028

Dublin, April 02, 2024 (GLOBE NEWSWIRE) The

United statesHappify healthOmada health incMindable health gmbAkili incTeladoc health incFreespira incRising demand for digital solutionsMorrow incKaia health software gmbTwill incNoom incResearch product developmentWelldoc incHeadspace healthPropeller health

Looking Better: Digital therapy reduces liver fat in 90 days

Better Therapeutics Inc.’s prescription digital therapeutic (PDT) received U.S. FDA breakthrough device designation for metabolic dysfunction-associated steatohepatitis (MASH), an advanced form of fatty liver disease that increases the risk of cirrhosis, liver failure and liver cancer but has few good treatments available.

Better therapeutics incBetter therapeuticsBioworld medtechBetter therapeutics incPrescription digital therapeuticMetabolic dysfunction associated liver diseaseMetabolic dysfunction associated steatotic liver diseaseNon alcoholic fatty liver diseaseNon alcoholic steatohepatitisMetabolic dysfunction associated steatohepatitisBreakthrough device designation